Ectoine-Containing Inhalation Solution versus Saline Inhalation Solution in the Treatment of Acute Bronchitis and Acute Respiratory Infections: A Prospective, Controlled, Observational Study

Table 2

Reductions in symptom scores from V1 to V2 and from V1 to FU.

Variables	Treatment	Reduction in symptom score from V1 to V2 (mean ± SD)	Reduction in symptom score from V1 to FU (mean ± SD)
BSS	Ectoine	5.13 ± 3.11	5.35 ± 3.75
	Saline	4.71 ± 3.57	5.40 ± 2.98
Cough	Ectoine	1.48 ± 1.06	1.66 ± 1.09
	Saline	1.38 ± 1.25	1.60 ± 1.10
Chest pain when coughing	Ectoine	1.00 ± 1.05	1.06 ± 1.16
	Saline	0.94 ± 0.92	1.08 ± 0.81
Auscultation findings	Ectoine	0.91 ± 0.96	0.83 ± 1.16
	Saline	0.69 ± 0.88	0.76 ± 0.78
Dyspnea	Ectoine	0.61 ± 0.94	0.57 ± 1.08
	Saline	0.54 ± 0.91	0.53 ± 0.90
Expectoration	Ectoine	0.99 ± 0.97	1.13 ± 1.08
	Saline	1.04 ± 1.01	1.15 ± 0.98

BSS: Bronchitis Severity Score; FU: follow-up; SD: standard deviation; V1: Visit 1; V2: Visit 2.